Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

December 15, 2024

Conditions
Type1diabetes
Interventions
DEVICE

Insulin pump

Continuous subcutaneous insulin therapy.

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT06347783 - Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes | Biotech Hunter | Biotech Hunter